Drugs. Picture: RUSSELL ROBERTS
Drugs. Picture: RUSSELL ROBERTS

Steven Schultz from Momentum chose Bristol-Myers Squibb as his stock pick of the day.

“My stock pick today is a US-listed biopharm by the name of Bristol-Myers Squibb. It is a specialist in immune-oncology treatments and it’s a company that’s been around for 80 years, so an exceptionally strong balance sheet.

Or listen to the full audio: